In collaboration with his colleagues at TGen, Dr. Bryce is at the forefront of cancer genomics and novel therapeutics for prostate cancer. His research focuses on cancer genetics, novel therapies and immunotherapeutic approaches in the search for a cure for prostate cancer. Dr. Bryce studies the power of leveraging cancer genomics and believes we can treat each patient with the best drug for his individual situation.
Throughout his career, Dr. Bryce has been widely published and received numerous honors and awards. He is board certified in internal medicine, hematology and medical oncology and is a member of several professional organizations, including the American Association of Clinical Oncology (ASCO), and is the genitourinary chair for Academic and Community Cancer Research United.